The Long Run with Luke Timmerman
Timmerman Report
"The Long Run"
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Episodes
Mentioned books
Jun 12, 2019 • 1h 7min
Ep46: Liz O'Day
Liz O'Day on metabolite signatures for predicting cancer drug response.
May 22, 2019 • 1h 11min
Ep45: Jay Bradner
Jay Bradner, president of Novartis Institutes for Biomedical Research, on his journey from open biology advocate to pharma leadership.
May 9, 2019 • 1h 12min
Ep44: Sheila Gujrathi
Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer
Apr 24, 2019 • 1h 12min
Ep43: Jeff Jonas
Sage Therapeutics CEO on psychiatric drug development.
Apr 9, 2019 • 1h 9min
Ep42: Carolyn Bertozzi
Carolyn Bertozzi on becoming a chemical biologist/glycobiologist.
Mar 27, 2019 • 1h 7min
Ep41: Bob Langer
MIT's Bob Langer on his journey in science and entrepreneurship.
Mar 13, 2019 • 1h 10min
Ep40: Serge Saxonov
Serge Saxonov on the single-cell analysis revolution.
Feb 26, 2019 • 1h 10min
Ep39: Julia Owens
Julia Owens on pivoting, more than once, in a biotech startup.
Feb 13, 2019 • 1h 10min
Ep38: Harlan and Chad Robins (Take 2)
The co-founders of Adaptive Biotechnologies on immune sequencing.
Jan 29, 2019 • 1h 10min
Ep37: Bonnie Anderson
Bonnie Anderson of Veracyte on genomic diagnostics.
